Xolremdi (mavorixafor) - X4 Pharma, Norgine
https://ashpublications.org/blood/article/146/Supplement%201/8229/553826/Trial-in-progress-A-pivotal-Phase-3-study-to
 
Deborah Steiner 1; Margo Jaffee 1; Katrina Adell 1; Sara Campetti 1; Katherine Carter 1; Henry Wu 1; Susan Dubuc 1; Shelby Abel 1; Emmanuel Adeniji 1; Sunny Li 1; Nour Ziyadeh 1; Sam Wilson 1; Xiaoxi Li 1; Christophe Arbet-Engels 1
 
Dec 5, 2025
 
Next